A carrageenan/agarose composite sponge and its immunomodulatory activities toward RAW264.7
Source abstract
Abstract
Abstract A kind of commercial hybrid carrageenan (HC)/agarose composite sponge containing κ‐, μ‐, ι‐, and ν‐carrageenan, which could turn into hydrogel and release carrageenan at human body temperature was fabricated for immune stimulation and modulation. Release behavior demonstrated that the hybrid carrageenan contained sponge was mechanically stable and could release carrageenan constantly. RT‐PCR and ELISA experiments showed that the leaching liquor of the sponge could stimulate RAW264.7 from M0 state to a polarized state by secreting more anti‐inflammatory factor IL‐10 than pro‐inflammatory ones, such as, IL‐6 and TNF‐α. Transwell experiments also indicated that the leaching liquor could promote the proliferation of NIH‐3T3 by stimulating RAW264.7 of M0 state after 7 days. Results of particle size and intracellular concentration analyses suggested that the released carrageenan might enter into the cellular interior of RAW264.7 in the form of microgels or protein complexes. The sponge would be a promising candidate for skin wound dressing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Seaweed-derived Bioactive Compounds · Marine Sponges and Natural Products · Echinoderm biology and ecology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering College of Life Science and Technology, Jinan University Guangzhou China
National Engineering Research Center for Tissue Restoration and Reconstruction School of Materials Science and Engineering, South China University of Technology Guangzhou China
Funding
National Natural Science Foundation of China
References (56)
Show source-provided references
1. 10.1007/s13671-016-0162-510.1007/s13671-016-0162-5 ↗
2. 10.1177/120347541666403710.1177/1203475416664037 ↗
3. 10.1038/nature0566410.1038/nature05664 ↗
4. 10.3390/ijms1712197410.3390/ijms17121974 ↗
5. 10.1016/j.biotechadv.2011.01.00510.1016/j.biotechadv.2011.01.005 ↗
6. 10.1016/j.msec.2016.11.09510.1016/j.msec.2016.11.095 ↗
7. 10.1007/s40820-016-0103-710.1007/s40820-016-0103-7 ↗
8. 10.1126/science.125383610.1126/science.1253836 ↗
9. 10.1186/1478-811X-11-2910.1186/1478-811X-11-29 ↗
10. 10.1016/j.biomaterials.2010.07.10110.1016/j.biomaterials.2010.07.101 ↗
11. 10.1016/j.biomaterials.2011.05.07810.1016/j.biomaterials.2011.05.078 ↗
12. 10.1146/annurev-bioeng-071813-10481410.1146/annurev-bioeng-071813-104814 ↗
13. 10.1016/j.mattod.2015.01.01910.1016/j.mattod.2015.01.019 ↗
14. 10.3390/md902019610.3390/md9020196 ↗
15. 10.1016/j.biomaterials.2019.05.02510.1016/j.biomaterials.2019.05.025 ↗
16. 10.1016/j.tifs.2019.08.00810.1016/j.tifs.2019.08.008 ↗
17. 10.1016/j.ijbiomac.2016.11.09510.1016/j.ijbiomac.2016.11.095 ↗
18. 10.1016/j.carbpol.2017.12.00910.1016/j.carbpol.2017.12.009 ↗
19. 10.1016/j.ijbiomac.2016.06.10110.1016/j.ijbiomac.2016.06.101 ↗
20. 10.1016/j.carbpol.2014.11.06310.1016/j.carbpol.2014.11.063 ↗
21. 10.1016/j.carbpol.2010.10.06210.1016/j.carbpol.2010.10.062 ↗
22. 10.1016/j.carbpol.2017.07.00910.1016/j.carbpol.2017.07.009 ↗
23. 10.1016/j.ijbiomac.2016.06.02110.1016/j.ijbiomac.2016.06.021 ↗
24. 10.1016/j.ijbiomac.2011.08.03210.1016/j.ijbiomac.2011.08.032 ↗
25. 10.1016/j.carbpol.2015.05.07910.1016/j.carbpol.2015.05.079 ↗
26. 10.1016/j.tifs.2018.02.01010.1016/j.tifs.2018.02.010 ↗
27. 10.1016/j.carbpol.2010.04.00210.1016/j.carbpol.2010.04.002 ↗
28. 10.1016/j.carbpol.2013.10.01010.1016/j.carbpol.2013.10.010 ↗
29. 10.1016/j.carbpol.2014.01.06710.1016/j.carbpol.2014.01.067 ↗
30. 10.1007/BF0198330710.1007/BF01983307 ↗
31. 10.1039/C7FO01721A10.1039/C7FO01721A ↗
32. 10.1016/j.nimb.2006.11.10110.1016/j.nimb.2006.11.101 ↗
33. 10.1016/j.ijpharm.2013.12.01510.1016/j.ijpharm.2013.12.015 ↗
34. 10.1080/096702603100013636710.1080/0967026031000136367 ↗
35. 10.1007/BF0196762510.1007/BF01967625 ↗
36. 10.1016/j.carbpol.2009.07.01010.1016/j.carbpol.2009.07.010 ↗
37. SOaSM. Effects of Carrageenan on immune responses: II. A possible regulatory role of macrophages in the immune responses of low responder mice
38. 10.1247/csf.29.2710.1247/csf.29.27 ↗
39. 10.1080/0962935989117110.1080/09629359891171 ↗
40. 10.1038/srep1106210.1038/srep11062 ↗
41. 10.1016/j.fct.2016.07.00610.1016/j.fct.2016.07.006 ↗
42. 10.1016/j.jnutbio.2009.07.00210.1016/j.jnutbio.2009.07.002 ↗
43. 10.1016/j.bbagen.2014.03.01110.1016/j.bbagen.2014.03.011 ↗
44. 10.1016/j.neuint.2012.06.01910.1016/j.neuint.2012.06.019 ↗
45. 10.1016/j.canlet.2005.11.03210.1016/j.canlet.2005.11.032 ↗
46. 10.1016/j.carbpol.2015.02.06910.1016/j.carbpol.2015.02.069 ↗
47. 10.1016/j.etap.2017.06.01010.1016/j.etap.2017.06.010 ↗
48. 10.1016/j.carbpol.2011.08.05310.1016/j.carbpol.2011.08.053 ↗
49. 10.1002/jbm.a.3601510.1002/jbm.a.36015 ↗
50. 10.1111/j.1750-3841.2012.02988.x10.1111/j.1750-3841.2012.02988.x ↗
51. 10.1021/bm005583j10.1021/bm005583j ↗
52. 10.1021/ac00096a01810.1021/ac00096a018 ↗
53. 10.1080/00032719.2015.112683910.1080/00032719.2015.1126839 ↗
54. 10.1016/j.antiviral.2014.05.01810.1016/j.antiviral.2014.05.018 ↗
55. 10.1016/j.carbpol.2017.02.02910.1016/j.carbpol.2017.02.029 ↗
56. 10.1042/bj084010610.1042/bj0840106 ↗